Evidence map›Paper›PMID 31448897›Full record

ArticleBiochemistry2019

APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.

Samantha J Ziegler, Yingxia Hu, Swapnil C Devarkar, Yong Xiong

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Samantha J ZieglerDepartment of Molecular Biophysics and Biochemistry , Yale University , New Haven , Connecticut 06511 , United States.
Yingxia HuDepartment of Molecular Biophysics and Biochemistry , Yale University , New Haven , Connecticut 06511 , United States.
Swapnil C DevarkarDepartment of Molecular Biophysics and Biochemistry , Yale University , New Haven , Connecticut 06511 , United States.
Yong XiongDepartment of Molecular Biophysics and Biochemistry , Yale University , New Haven , Connecticut 06511 , United States.ORCID 0000-0001-9625-9313
Yale University · US

Funding

INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, David G. Schatz · 1985 to 2026
$14.4M
Multifaceted interactions between lentiviral Vif and host molecules for viral infectivity enhancementR37AI116313 · NIAID · YALE UNIVERSITY · PI Yong Xiong · 2021 to 2026
$3.2M
Recognition of Viral DNA by APOBEC3 Proteins and their Antagonization by HIV VifR01AI116313 · NIAID · YALE UNIVERSITY · PI XIONG, YONG · 2015 to 2019
$2.1M
NIAID NIH HHS R01 AI116313NIAID NIH HHS R37 AI116313NIAID NIH HHS T32 AI007019
6 · The paper itself

Abstract

The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3 or A3) family of proteins functions in the innate immune system. The A3 proteins are interferon inducible and hypermutate deoxycytidine to deoxyuridine in foreign single-stranded DNA (ssDNA). However, this deaminase activity cannot discriminate between foreign and host ssDNA at the biochemical level, which presents a significant danger when A3 proteins gain access to the nucleus. Interestingly, this A3 capability can be harnessed when coupled with novel CRISPR-Cas9 proteins to create a targeted base editor. Specifically, A3A has been used

Indexed as

Amino Acid SequenceCytidine DeaminaseDeaminationDNA, Single-StrandedHumansMutationProtein BindingProteinsProtein Structure, SecondaryAPOBEC3A protein, humanCytidine DeaminaseDNA, Single-StrandedProteins

Identifiers

PMID31448897
PMCPMC7211764
OpenAlexW2970766518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.